Official approval by the UK National Institute for Health and Care Excellence (NICE) of the drugs Epidyolex and Sativex will be seen by many as a positive sign of growing acceptance of cannabis-based medicines ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.